MORE medicines used for the treatment of cancer, diabetes and mental illness have been added to the list of value-added tax (VAT)-exempt drugs, according to the Bureau of Internal Revenue (BIR).

Despite this escalating demand for popular GLP-1 drugs, the prices for some of these products are actually dropping. Dr.

Novo Nordisk made a submission to the U.S. Food and Drug Administration (FDA) nominating Novo Nordisk’s semaglutide ...

Lawsuits filed in New Jersey are part of hundreds of complaints against UnitedHealthcare, PBMs, and pharmaceutical giants ...

It’s likely to still be there at the end of the year, but by the time the final sales figures for 2024 are tallied up, Novo ...

But weight loss alone does not explain the drugs’ benefits. Both Holst and Sattar pointed to a discontinued GLP-1 drug once ...

Weight loss drugs, compounding, vitamin D, and AI all piqued readers’ interest — and sometimes, ire — this past year.

They are currently approved for treating diabetes, obesity and those with a history of cardiovascular disease in people who ...

We recently compiled a list of the 12 Best Weight Loss Stocks to Buy According to Hedge Funds. In this article, we are going ...

Over half of American adults are eligible for semaglutide, but insurance and other barriers make it hard for people to access ...

Elon Musk, the richest person alive and the co-head of President-elect Donald Trump’s new Department of Government Efficiency ...